ERYTECH provides business update and financial results for the first half of 2015 admERY September 28, 2015 Newsroom ERYTECH provides a business update and reports its financial results for the six-month period ending June 30, 2015. You Might Also Like ERYTECH to Present Full Results for Phase 2b Trial of eryaspase in Pancreatic Cancer at ESMO 2017 August 31, 2017 ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government November 2, 2020 ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. June 17, 2012
ERYTECH to Present Full Results for Phase 2b Trial of eryaspase in Pancreatic Cancer at ESMO 2017 August 31, 2017
ERYTECH Secures €10 Million in Non-Dilutive Financing, Guaranteed by the French Government November 2, 2020
ERYTECH Pharma announces the oral presentation of positive Phase II clinical trial results in Acute Lymphoblastic Leukemia. June 17, 2012
